New study suggests men and women may benefit differently from some immunotherapy medications

In a recent review study, an immunotherapy treatment for advanced cancers improved overall survival in both men and women compared to the other treatments, but the relative survival gain almost doubled in men, compared to female patients, regardless of the type of cancer and drugs given.

Read more about the impact of this study in this Immuno-Oncology News article